| Financial Year |
March 31 2023 |
| Monetary Funds |
1,354,201,311.52 |
| Held-for-trading Financial Assets |
1,822,305,339.70 |
| Notes Receivable |
-- |
| Accounts Receivable |
819,073,844.59 |
| Advances to Suppliers |
52,020,804.96 |
| Other Receivables |
46,952,403.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,942,648,653.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,501,745,672.37 |
| Total Current Assets |
7,538,948,029.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
369,630,219.59 |
| Investment Properties |
13,155,853.98 |
| Fixed Assetes |
100,338,070.73 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
20,057,548.60 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
37,724,406.52 |
| Deferred Income Tax Assets |
246,794,967.70 |
| Other Non-Current Assets |
1,241,049,598.79 |
| Sub-Total of Non-Current Assets |
3,138,501,262.40 |
| Total Assets |
10,677,449,292.09 |
| Short-Term Loans |
158,857,278.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
66,731,262.62 |
| Accounts Payable |
972,159,081.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
308,184,601.43 |
| Taxes Payable |
139,697,914.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
330,338,943.36 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
161,650,219.29 |
| Other Current Liabilities |
76,505,857.28 |
| Sub-Total of Current Liabilities |
2,329,663,481.94 |
| Long-term Loans |
610,700,000.00 |
| Bonds Payable |
2,067,720.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
96,928,172.64 |
| Deferred Income Tax Liabilities |
96,912,361.06 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,104,023,576.90 |
| Total Liabilities |
3,433,687,058.84 |
| Paid-In Capital(Or Share Stock) |
406,427,207.00 |
| Capital Surplus |
3,002,511,217.82 |
| Surplus Reserve |
203,213,603.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,551,022,936.89 |
| Minority Stockholder's Interest |
105,001,126.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,138,761,107.16 |
| Owner's Equity（Stockholder's Equity） |
7,243,762,233.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,677,449,292.09 |
